SCHEMBL1325564

SCHEMBL1325564

CCCCCCCc1ccc(C(N)=NO)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.62
RAB9A P51151 2/20 0.62
LMNA P02545 2/20 0.62
TP53 P04637 2/20 0.62
HSD17B10 Q99714 2/20 0.62
NPC1 O15118 1/20 0.62
MAPT P10636 1/20 0.62
ALOX15 P16050 1/20 0.62
ESR1 P03372 2/20 0.55
ADRA2A P08913 2/20 0.55
ADORA3 P0DMS8 2/20 0.55
TACR2 P21452 2/20 0.55
SLC6A2 P23975 2/20 0.55
SLC6A4 P31645 2/20 0.55
SLC6A3 Q01959 2/20 0.55
KDM4E B2RXH2 1/20 0.55
ALDH1A1 P00352 1/20 0.55
SHBG P04278 1/20 0.55
CYP3A4 P08684 1/20 0.55
HSPD1 P10809 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1325562 1.00 GAA (0.62) GAARAB9ALMNATP53HSD17B10
SCHEMBL16934339 1.00 GAA (0.62) GAARAB9ALMNATP53HSD17B10
SCHEMBL15176436 1.00 GAA (0.62) GAARAB9ALMNATP53HSD17B10
SCHEMBL16934342 1.00 GAA (0.62) GAARAB9ALMNATP53HSD17B10
SCHEMBL15176411 1.00 GAA (0.62) GAARAB9ALMNATP53HSD17B10
SCHEMBL15174362 1.00 GAA (0.62) GAARAB9ALMNATP53HSD17B10
SCHEMBL15174459 1.00 GAA (0.62) GAARAB9ALMNATP53HSD17B10
SCHEMBL22265414 1.00 GAA (0.62) GAARAB9ALMNATP53HSD17B10
SCHEMBL22265415 1.00 GAA (0.62) GAARAB9ALMNATP53HSD17B10
SCHEMBL16934110 1.00 GAA (0.62) GAARAB9ALMNATP53HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110275673-A1 INHIBITORS OF SPHINGOSINE KINASE 1 GENZYME CORPORATION 2011-11-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110275673-A1 INHIBITORS OF SPHINGOSINE KINASE 1 SPHK1, SPHK2, S1PR1 GAA 949/4885RAB9A 3029/4885LMNA 2971/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.